Simplex Trading’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
DTC
TCM
RCM
Simplex Trading's ALT Position: Q2 2026 in Review
Simplex Trading sold out of Altimmune (ALT) in Q2 2026, closing a stake of 22,841 shares — an estimated $68.2K sold.
Simplex Trading first reported a position in ALT in Q3 2016 and held it in 20 quarters. The position peaked at $3.73M in Q4 2022. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- Simplex Trading reported no remaining Altimmune position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 22,841 Altimmune shares in Q2 2026, an estimated $68.2K.
- Simplex Trading first reported a position in Altimmune in Q3 2016 and held it in 20 quarters.
- Simplex Trading's Altimmune position peaked at $3.73M in Q4 2022.
- 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.